BetterBread: developing novel milling processes for improved nutrition in white wheat flour without fortification.
BetterBread:开发新颖的研磨工艺,以改善未经强化的白小麦粉的营养。
基本信息
- 批准号:10074325
- 负责人:
- 金额:$ 66.87万
- 依托单位:
- 依托单位国家:英国
- 项目类别:Collaborative R&D
- 财政年份:2023
- 资助国家:英国
- 起止时间:2023 至 无数据
- 项目状态:未结题
- 来源:
- 关键词:
项目摘要
Founded in 1979, Shipton Mill (Shipton) is the largest UK organic flour mill and a Royal Warrant Holder that specialises in creating award-winning, natural, and organic flours. Sustainability is central to Shipton and the mill is 100% powered by renewable energy. All their packaging is plastic-free, and they work closely with local organic farms.Shipton is a highly successful milling company that consistently launches new and unique, award-winning flours. Shipton works alongside multiple large companies to innovate new products that have been very successful in the marketplace. Shipton is an integral part of a company group that includes other specialist bakeries, whom they have previously successfully collaborated with.The primary consumer motivations underpinning this opportunity include demand for:* cost-effective health benefits including increased nutritional value* 'all-natural', clean-label products with reduced/no added preservativesRegulations (Bread&Flour Regulations,1998) have been introduced to add calcium, iron, thiamine (Vitamin B1) and niacin (Vitamin B3) to all white and brown flour.Shipton will be collaborating with Aberystwyth University, a leading Welsh university, who will be supporting nutritional analysis during this project. With this project, Shipton and Aberystwyth University are seeking to improve the nutritional quality of flour by altering blend composition and implementing modifications to the milling process.The project will bring significant social and economic benefits to the UK and will further establish the UK as a leader in the flour and flour-based foods markets.
成立于1979年,Shipton Mill(Shipton)是英国最大的有机面粉厂和皇家授权保持器,专门生产屡获殊荣的天然有机面粉。可持续发展是希普顿的核心,工厂100%由可再生能源供电。他们所有的包装都是无塑料的,他们与当地的有机农场密切合作。Shipton是一家非常成功的面粉公司,不断推出新的和独特的,屡获殊荣的面粉。Shipton与多家大型公司合作,创新在市场上非常成功的新产品。Shipton是一个公司集团的一个组成部分,该集团包括其他专业面包店,他们以前曾成功地与之合作。支撑这一机会的主要消费者动机包括以下需求:* 具有成本效益的健康益处,包括增加营养价值 *“全天然”,清洁标签产品,减少/不添加维生素(面包和面粉法规,1998年)已被引入添加钙,铁,硫胺素(维生素B1)和烟酸(维生素B3)添加到所有白色和棕色面粉中。希普顿将与威尔士领先的阿伯里斯特威斯大学合作,世卫组织将在该项目期间支持营养分析。通过这个项目,Shipton和阿伯里斯特威斯大学正在寻求通过改变混合成分和对碾磨过程进行修改来提高面粉的营养质量。该项目将为英国带来显著的社会和经济效益,并将进一步确立英国在面粉和面粉食品市场的领导地位。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
其他文献
吉治仁志 他: "トランスジェニックマウスによるTIMP-1の線維化促進機序"最新医学. 55. 1781-1787 (2000)
Hitoshi Yoshiji 等:“转基因小鼠中 TIMP-1 的促纤维化机制”现代医学 55. 1781-1787 (2000)。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
LiDAR Implementations for Autonomous Vehicle Applications
- DOI:
- 发表时间:
2021 - 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
吉治仁志 他: "イラスト医学&サイエンスシリーズ血管の分子医学"羊土社(渋谷正史編). 125 (2000)
Hitoshi Yoshiji 等人:“血管医学与科学系列分子医学图解”Yodosha(涉谷正志编辑)125(2000)。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Effect of manidipine hydrochloride,a calcium antagonist,on isoproterenol-induced left ventricular hypertrophy: "Yoshiyama,M.,Takeuchi,K.,Kim,S.,Hanatani,A.,Omura,T.,Toda,I.,Akioka,K.,Teragaki,M.,Iwao,H.and Yoshikawa,J." Jpn Circ J. 62(1). 47-52 (1998)
钙拮抗剂盐酸马尼地平对异丙肾上腺素引起的左心室肥厚的影响:“Yoshiyama,M.,Takeuchi,K.,Kim,S.,Hanatani,A.,Omura,T.,Toda,I.,Akioka,
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('', 18)}}的其他基金
An implantable biosensor microsystem for real-time measurement of circulating biomarkers
用于实时测量循环生物标志物的植入式生物传感器微系统
- 批准号:
2901954 - 财政年份:2028
- 资助金额:
$ 66.87万 - 项目类别:
Studentship
Exploiting the polysaccharide breakdown capacity of the human gut microbiome to develop environmentally sustainable dishwashing solutions
利用人类肠道微生物群的多糖分解能力来开发环境可持续的洗碗解决方案
- 批准号:
2896097 - 财政年份:2027
- 资助金额:
$ 66.87万 - 项目类别:
Studentship
A Robot that Swims Through Granular Materials
可以在颗粒材料中游动的机器人
- 批准号:
2780268 - 财政年份:2027
- 资助金额:
$ 66.87万 - 项目类别:
Studentship
Likelihood and impact of severe space weather events on the resilience of nuclear power and safeguards monitoring.
严重空间天气事件对核电和保障监督的恢复力的可能性和影响。
- 批准号:
2908918 - 财政年份:2027
- 资助金额:
$ 66.87万 - 项目类别:
Studentship
Proton, alpha and gamma irradiation assisted stress corrosion cracking: understanding the fuel-stainless steel interface
质子、α 和 γ 辐照辅助应力腐蚀开裂:了解燃料-不锈钢界面
- 批准号:
2908693 - 财政年份:2027
- 资助金额:
$ 66.87万 - 项目类别:
Studentship
Field Assisted Sintering of Nuclear Fuel Simulants
核燃料模拟物的现场辅助烧结
- 批准号:
2908917 - 财政年份:2027
- 资助金额:
$ 66.87万 - 项目类别:
Studentship
Assessment of new fatigue capable titanium alloys for aerospace applications
评估用于航空航天应用的新型抗疲劳钛合金
- 批准号:
2879438 - 财政年份:2027
- 资助金额:
$ 66.87万 - 项目类别:
Studentship
Developing a 3D printed skin model using a Dextran - Collagen hydrogel to analyse the cellular and epigenetic effects of interleukin-17 inhibitors in
使用右旋糖酐-胶原蛋白水凝胶开发 3D 打印皮肤模型,以分析白细胞介素 17 抑制剂的细胞和表观遗传效应
- 批准号:
2890513 - 财政年份:2027
- 资助金额:
$ 66.87万 - 项目类别:
Studentship
CDT year 1 so TBC in Oct 2024
CDT 第 1 年,预计 2024 年 10 月
- 批准号:
2879865 - 财政年份:2027
- 资助金额:
$ 66.87万 - 项目类别:
Studentship
Understanding the interplay between the gut microbiome, behavior and urbanisation in wild birds
了解野生鸟类肠道微生物组、行为和城市化之间的相互作用
- 批准号:
2876993 - 财政年份:2027
- 资助金额:
$ 66.87万 - 项目类别:
Studentship
相似海外基金
Towards sustainable cultured meat production by developing a novel biocatalyst
通过开发新型生物催化剂实现可持续的培养肉生产
- 批准号:
BB/Y007859/1 - 财政年份:2024
- 资助金额:
$ 66.87万 - 项目类别:
Research Grant
Developing a new generation of tools for predicting novel AMR mutation profiles using generative AI
使用生成人工智能开发新一代工具来预测新型 AMR 突变谱
- 批准号:
BB/Z514305/1 - 财政年份:2024
- 资助金额:
$ 66.87万 - 项目类别:
Research Grant
Collaborative Research: DMREF: Developing and Harnessing the Platform of Quasi-One-Dimensional Topological Materials for Novel Functionalities and Devices
合作研究:DMREF:开发和利用用于新功能和器件的准一维拓扑材料平台
- 批准号:
2324033 - 财政年份:2023
- 资助金额:
$ 66.87万 - 项目类别:
Standard Grant
DEVELOPING A HUMAN STEM CELL-DERIVED HEART MODEL TO CHARACTERIZE A NOVEL ARRHYTHMIA SYNDROME
开发人类干细胞衍生的心脏模型来表征新型心律失常综合征
- 批准号:
495592 - 财政年份:2023
- 资助金额:
$ 66.87万 - 项目类别:
Developing novel, potent, and brain permeable inhibitors of inosine monophosphate dehydrogenase to prevent brain metastases
开发新型、有效且脑可渗透的肌苷单磷酸脱氢酶抑制剂以预防脑转移
- 批准号:
496426 - 财政年份:2023
- 资助金额:
$ 66.87万 - 项目类别:
Fellowship Programs
Developing a novel Climate change Risk Assessment Framework for cultural heritage in Turkey (CRAFT)- Phase II
为土耳其文化遗产制定新颖的气候变化风险评估框架(CRAFT)-第二阶段
- 批准号:
AH/X006816/1 - 财政年份:2023
- 资助金额:
$ 66.87万 - 项目类别:
Research Grant
Cicero - Developing chickpea as a novel source of domestic UK protein
西塞罗 - 将鹰嘴豆开发为英国国内蛋白质的新来源
- 批准号:
10052996 - 财政年份:2023
- 资助金额:
$ 66.87万 - 项目类别:
Collaborative R&D
HoloMem: Developing a novel holographic data storage technology to address the growing need within global data storage
HoloMem:开发一种新颖的全息数据存储技术,以满足全球数据存储日益增长的需求
- 批准号:
10049468 - 财政年份:2023
- 资助金额:
$ 66.87万 - 项目类别:
Collaborative R&D
Developing and testing a novel self-guided digital therapeutic solution for preventing stammering in children: incorporating latest research on early detection and progress evaluation using real-world data
开发和测试一种新颖的自我引导数字治疗解决方案,用于预防儿童口吃:结合使用真实世界数据进行早期检测和进展评估的最新研究
- 批准号:
10072187 - 财政年份:2023
- 资助金额:
$ 66.87万 - 项目类别:
Collaborative R&D
Developing Novel Technology for Data Driven Clinical Decision Making
开发数据驱动临床决策的新技术
- 批准号:
MR/Y007816/1 - 财政年份:2023
- 资助金额:
$ 66.87万 - 项目类别:
Research Grant